Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis

Journal of Orthopaedic Research

Volumn 25, Issue 5, 2007, Pages 563-568

  Hasegawa, Masahiro ^a   Nakoshi, Yutaka ^a   Muraki, Makoto ^a   Sudo, Akihiro ^a   Kinoshita, Noriaki ^b   Yoshida, Toshimichi ^a   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b IBL Co Ltd   (Japan)

Author keywords

Biochemical marker; Osteoarthritis; Rheumatoid arthritis; Synovial fluid; Tenascin C

Indexed keywords

C REACTIVE PROTEIN; TENASCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SAMPLING; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; SYNOVIUM; WESTERN BLOTTING;

ADULT; ALTERNATIVE SPLICING; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; SYNOVIAL FLUID; TENASCIN;

EID: 34248356820     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20366     Document Type: Article

References (24)

1. Kay J, Calabrese L. 2004. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 43(Suppl 3):iii2-iii9.
2. Manicourt DH, Poilvache P, Van Egeren A, et al. 2000. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 43:281-288.
3. Tsunoda T, Inada H, Kalembeyi I, et al. 2003. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 162:1857-1867.
4. Hasegawa M, Hirata H, Sudo A, et al. 2004. Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis. J Rheumatol 31:2021-2026.
5. Savarese JJ, Erickson H, Scully SP. 1996. Articular chondrocyte tenascin-C production and assembly into de novo extracellular matrix. J Orthop Res 14:273-281.
6. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, et al. 1986. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-139.
7. Jones PL, Jones FS. 2000. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 19:581-596.
8. Ghert MA, Qi WN, Erickson HP, et al. 2002. Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells. J Orthop Res 20:834-841.
9. Salter DM. 1993. Tenascin is increased in cartilage and synovium from arthritic knees. Br J Rheumatol 32:780-786.
10. Arnett FC, Edworthy SM, Bloch DA, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324.
11. Imanaka-Yoshida K, Hiroe M, Yasutomi Y, et al. 2002. Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol 197:388-394.
12. Shou J, Bull CM, Li L, et al. 2006. Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Arthritis Res Ther 8: R28.
13. Garnero P, Geusens P, Landewe R. 2003. Biochemical markers of joint tissue turnover in early rheumatoid arthritis. Clin Exp Rheumatol 21(5 Suppl):S54-S58.
14. McCachren SS, Lightner VA. 1992. Expression of human tenascin in synovitis and its regulation by interleukin-1. Arthritis Rheum 35:1185-1196.
15. Vingsbo-Lundberg C, Saxne T, Olsson H, et al. 1998. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum 41:544-550.
16. Rettig WJ, Erickson HP, Albino AP, et al. 1994. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J Cell Sci 107:487-497.
17. Mackie EJ, Scott-Burden T, Hahn AW, et al. 1992. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 141:377-388.
18. Tucker RP, Hammarback JA, Jenrath DA, et al. 1993. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci 104:69-76.
19. Pearson CA, Pearson D, Shibahara S, et al. 1988. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J 7: 2977-2982.
20. Ridderstad A, Abedi-Valugerdi M, Moller E. 1991. Cytokines in rheumatoid arthritis. Ann Med 23:219-223.
21. Kahle P, Saal JG, Schaudt K. 1992. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 51:731-734.
22. Manabe N, Oda H, Nakamura K, et al. 1999. Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. Rheumatology (Oxford) 38: 714-720.
23. Li TF, Warris V, Ma J, et al. 2000. Distribution of tenascin-X in different synovial samples and synovial membrane-like interface tissue from aseptic loosening of total hip replacement. Rheumatol Int 19:177-183.
24. Jarvinen TA, Kannus P, Jarvinen TL, et al. 2000. Tenascin-C in the pathobiology and healing process of musculoskeletal tissue injury. Scand J Med Sci Sports 10: 376-382.